Unbiased and Practical Psychopharmacology Updates
Get exclusive psychopharmacology updates. Earn up to 155 CMEs, including 40 SA CMEs credits.
Receive psychopharmacology updates in your inbox
TRENDING IN PSYCHOPHARMACOLOGY INSTITUTE
Quick Takes
“Cade’s Disease” and Beyond: Misdiagnosis, Antidepressant Use, and a Proposed Definition for Bipolar Spectrum Disorder
Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis
Effect of Anxiolytic Drug Silexan on Sleep – A Narrative Review
Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial
Intermittent Selective Serotonin Reuptake Inhibitors for Premenstrual Syndromes: A Systematic Review and Meta-Analysis of Randomized Trials
View All
Expert Consultations
Pharmacotherapies for Stimulant Use Disorder – Interview
Pharmacologic Management of BPD: Recent Developments-Interview
Antipsychotic Switching: Intersection of Art and Science – Interview
Management of Behavioral and Psychological Symptoms of Dementia – Interview
OCD in Children and Adolescents – Interview
View All
Video Lectures
Initiating and Optimizing Clozapine
Treating Anxiety Disorders in Patients With Cancer
Prevalence, Assessment, and Management of RBD
Considerations for Using Benzodiazepines and Benzodiazepine Receptor Agonists in the Geriatric Population
Use of Omega-3 Fatty Acids in Children and Adolescents
View All
RECENT PUBLICATIONS
2025 in Review: FDA Approvals, Practice Guidelines, and Label Changes in Psychiatry
Pharmacotherapy of Eating Disorders: An Update – Interview
Psychotropic-Induced Movement Disorders and Cognitive Side Effects (Update)
Quick Take Vol. 81
Serotonin Syndrome: Mechanisms, Diagnosis, High-Risk Interactions, and Management
Updates on Geriatric Psychopharmacology
Explore our library of over 480 video lectures, podcasts, research summaries, and expert interviews.
CME Information
Physicians – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.
This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Nursing professionals – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.
This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The ANCC accepts AMA PRA Category 1 Credit(s)™ as Contact Hours, under this calculation: 1 CME = 1 Contact Hour.
Physician assistants – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.
This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Self Assessment for MOC – Accreditation Statement
- Psychopharmacology Institute Self-Assessment Program 2025
Dates: April 1, 2025 – April 1, 2028
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2025 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
- Psychopharmacology Institute Self-Assessment, 2023- Part 1
Dates: January 1, 2023 – January 1, 2026
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment, 2023- Part 1 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
- Psychopharmacology Institute Self-Assessment Program 2024
Dates: April 1, 2024 – April 1, 2027
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2024 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
Lost as a newly-matched psychiatry resident?
Access ALL our products FREE for 3 months!